Tierney

We present the principles for selecting and initiating hubs, the integration with secondary care services and the supply of personal protective equipment.

The main elements are communication, the development of referral processes to manage complex cases and data collection.

Through work with local dental stakeholders, 23 clusters…[Read more]

Length z-scores at 2 y but not at birth were positively correlated with mothers’ (r=0.21, P=0.002) and fathers’ height (r=0.22, P=0.001).

Nearly two-thirds of healthy term infants experienced either catch-up or catch-down in weight and length first 2 years of life. Infants’ birthweight and length at birth, caloric intake, and parents’…[Read more]

Further, the molecular docking of WP_096774744.1 enzyme with glucose revealed a distinct glucose-binding site distant from the substrate-binding site, thus confirming the deficient competitive inhibition by glucose. Hence, WP_096774744.1 β-glucosidase appears to be an efficient enzyme with enhanced activity to biodegrade the cellulosic materials…[Read more]

8% vs 3.2%, p 0.05). There was no difference in annual residual family income by cancer status; however, 3 lowest deciles of residual income representing 21.1% cancer-survivor with MI had a residual income of less then $9,000. MI continues to represent an immense source of financial and perceived stress. In conclusion, although cancer patients…[Read more]

There was a trend for an effect of the DRD2 Taq1A on the number of drinks per drinking day and for the interaction of gender and DRD2 Taq1A on the number of drinks per drinking day. Conclusion These findings suggest that the DRD2 Taq1A, OPRM1 A118G, DRD4 C521T, or COMT Val158Met polymorphisms, are not associated with alcohol consumption in young…[Read more]

Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to cause gastric mucosal damage, in which gastric hypermotility has been reported to play a primary role. The antipyretic analgesic drug ethenzamide (ETZ) is widely used in combination with other NSAIDs and, in a recent study, was found to possess 5-hydroxytriptamine (5HT)2B receptor…[Read more]

Cisplatin/gemcitabine is standard first-line treatment for patients with advanced biliary tract cancer (ABC). NUC-1031 (phosphoramidate transformation of gemcitabine) is designed to enhance efficacy by maximizing intratumoral active metabolites.

Patients with untreated ABC, Eastern Cooperative Oncology Group performance status 0-1 received…[Read more]